What You Should Know:
– PCA Rx and Cost Plus Drugs, are joining forces to tackle the longstanding issue of opaque and inflated drug pricing in the US healthcare system.
– This landmark collaboration paves the way for greater transparency, accessibility, and affordability for employers and individuals nationwide.
Prioritizing Drug Pricing Transparency
By prioritizing transparency, this partnership empowers employers and members to make informed choices and fosters a more engaged healthcare community. It signifies a major leap forward in transforming the industry’s approach to drug pricing and paves the way for a more accessible and affordable healthcare system for all.
PCA Rx, known for its transparent PBM model, and Cost Plus Drugs, the brainchild of Mark Cuban focused on cost-plus pricing, share a mission to empower patients and employers with clear information about medication costs. This partnership combines their expertise to offer an unprecedented level of clarity in drug pricing, addressing a major pain point in the healthcare sector.
This collaboration actively seeks solutions to prescription affordability challenges. Kelly Cromer, PharmD, VP Operations & Clinical at PCA Rx, emphasizes, “PCA Rx and Cost Plus Drugs are committed to lowering drug prices and enhancing transparency, empowering individuals and employers to make informed healthcare decisions.”
